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Aim: The aim of this study was to identify possible risk factors for current asthma 
revealed by two studies in Northern Norway in 1985 and 2008 and to evaluate these 
factors contribution to the increased prevalence of asthma over these 23 years,  
Methods: As part of the ‘Asthma and allergy study among schoolchildren in 
Nordland county’ we performed a case-control study (70.0% attendance) comparing 
153 children with current asthma (cases) to their non-asthmatic controls. The results 
from this 2008 study were compared to a similar case-control study (93.2% 
attendance) performed in 1985 based on 62 current asthmatics.  
Results: In 1985 the most important risk factors for current asthma were repeated 
lower respiratory tract infections (LRTIs) with adjusted odds ratio (aOR) 52.11, 
together with urticaria ever and atopic disease in the family. In 2008 the most 
important risk factors were food allergy with aOR7.06, LRTIs during the first 3 years 
of life with aOR 5.80 and hospitalisation caused by LRTIs.  
Conclusion: In both studies, LRTI was the most important risk factor 
for current asthma. Whether or not LRTIs have contributed to the 










 Two case-control studies in 1985 and 2008 demonstrated that 
lower respiratory tract infections were the most important risk 
factor for current asthma in subarctic schoolchildren 
populations. 
 Atopic diseases in the family had impact on current asthma, 
only in the 1985 study. 
 Whether or not lower respiratory tract infections have 
contributed to increased asthma prevalence in this population 









The substantial increase in the reported prevalence of asthma in the latter part of the 
20th century has been termed the ‘asthma epidemic’  (1). Despite decades of research, 
there has not been a significant breakthrough in the understanding of mechanisms, 
genetics, and effective preventive strategies for asthma. Asthma is a complex 
disease. Changes in the prevalence may be due to multiple genetic, and 
environmental determinants, each contributing a relatively small effect  (1,2). Rapid 
increase in asthma prevalence may indicate that environmental factors have a greater 
impact than genetic factors, even if parental asthma and, or, allergic 
rhinoconjunctivitis (AR) have often been identified as the strongest risk factors  
(3,4).  
 
During the period 1985-2008, three cross-sectional surveys to estimate the 
prevalence of parental reported asthma, AR and eczema  (5-7) were conducted 
among schoolchildren (7-14 years) in Nordland county, Norway. The results showed 
an increase in the prevalence of asthma ever from 7.3% to 17.6% and an increase in 
the prevalence of current asthma from 4.8% to 9.9%  (7). As part of the study 
‘Asthma and allergy among schoolchildren in Nordland County’ we used data from 
the questionnaire-based surveys in 1985 and 2008 to perform case-control studies 
designed to explore possible risk factors by comparing children with current asthma 
to non-asthmatic controls. The aim was to identify possible risk factors for current 
asthma in 1985 and 2008 respectively, and to evaluate their contribution to the 





PATIENTS AND METHODS 
 
Study design 
In 1985, a cross-sectional questionnaire-based survey concerning asthma, AR and 
eczema was distributed to randomly selected schoolchildren in Northern Norway 
aged 7-13 years  (5,8). ‘Asthma ever’ was considered if the parent answered yes to 
the question: Has the pupil ever had asthma? And, or, to the question: Does the pupil 
experience wheeze, periods of coughing or acute shortness of breath (asthma) due to 
external factors? The same questionnaire was used in identical surveys in 1995 and 
in 2008, throughout Northern Norway and in Nordland county  (6,7). 
 
To validate the questionnaire and to verify diagnosis and risk factors for asthma, 
case-control studies based on the cross-sectional surveys were performed in 1985 
and 2008, but not in 1995. Pupils who reported ever having asthma (cases) together 
with non-asthmatic controls matched for age, gender and school affiliation were 
invited to participate. Preferably, cases and controls went to the same school; 
however, when this premise was violated due to the small number of pupils at the 
school, the control was chosen from the same geographic area. Participating children 
together with their parents/guardians completed a questionnaire and a structured 
interview. The interview covered birth data, socio-economic conditions, health 
status, infections and asthma, second-hand smoke exposure and household animals. 
A clinical examination including height, and weight measurements and assessment 
of skin, upper airway, lung and heart was performed. In addition clinical testing was 






Based on the clinical assessment (interview and clinical examination) children were 
categorised as asthmatic or non-asthmatic and asthma severity was classified 
according to modified Kjell Aas scale, a system proposed by Norwegian paediatric 
allergologist  (9) in 1985 and to the GINA guidelines  (10) in 2008. The assessments 
fulfilling the definition criteria for current asthma (cases) and non-asthmatics age- 
and gender-matched controls were then compared.  
 
The 1985 study 
In 1985, 4870 schoolchildren (94.9% response rate) aged 7-13 years (51.4% male) 
from Nordland county participated in the cross-sectional questionnaire-based survey. 
Parents reported asthma ever in 353 children (7.3%) (Figure 1). Approximately one 
third of the children reporting asthma ever randomly selected, together with non-
asthmatic controls were invited to participate in a case-control study during 1986-
1987 (Figure 1). The children lived in different geographical areas in Nordland, 
representing both coast and inland. Of the 222 invited children, 207 (93.2% 
attendance) were enrolled in the case-control study. In addition to a structured 
interview, the participants underwent a clinical examination and clinical testing 
including spirometry and specific Immunoglobulin E (IgE). Skin prick tests (SPTs) 
were performed in cases only. One of the authors (JH), a paediatrician, conducted all 
interviews, examinations and tests. Data from this case-control study is previously 
unpublished.  
 




In 2008, 4150 (63.8% attendance) schoolchildren aged 7-14 years participated in the 
cross-sectional survey  (7). Using identical definitions as in 1985, 729 (17.6%) 
children reported asthma ever (Figure 2). Pupils who reported ever having asthma 
(cases) and who lived within two hour by car to the study locations in four different 
geographical areas in Nordland county, along with two age and gender matched non-
asthmatic controls were invited to participate. Of the invited, 801 children (70% 
attendance) were enrolled to the case control study. More controls (428) than cases 
(373) participated (Figure 2). 
 
In addition to a second questionnaire, a structured interview and clinical 
examination, spirometry, exercise treadmill testing (EIB test), SPTs, measurements 
of exhaled nitrogen oxide (FENO), sIgE and total IgE were obtained, a process 
described in detail elsewhere  (11,12). The participants were examined at least two 
weeks after any suspected respiratory tract infection during the school term from 
March 2009 to June 2010. Two of the authors (THE and BE) conducted all 
interviews and procedures. The same medical instruments were used to secure 
standardised measurements conditions.  
 
Definitions 
The children’s final diagnoses were confirmed by the doctor performing the clinical 
assessment, based on the information from the structured interviews and the clinical 
examination in the case-control studies.  
Asthma ever was defined as at least two of the three criteria being fulfilled; 1) 
recurrent dyspnoea, chest tightness and/or wheezing; 2) doctor’s diagnosis of 




corticosteroids, leukotriene antagonists and/or aminophylline)  (13). Current asthma 
was defined as asthma above plus symptoms and, or, asthma medication within the 
last year.  
Allergic rhinoconjunctivitis (AR) was defined as a history of watery rhinorrhea, 
blocked nose, sneezing, or nasal itching accompanied by itchy watery eyes in 
absence of airway infection.  
Eczema was defined as an itchy rash lasting at least 4 weeks combined with lesions 
on the face, elbows or knee flexures, or a high degree of itching and lesions 
elsewhere. 
Food allergy was defined as a history of IgE mediated food allergy symptoms as 
evaluated by a doctor. 
Current AR, eczema and food allergy was defined as symptoms within the last year. 
Allergic sensitisation was defined as: a positive SPT (wheal diameter ≥3 mm larger 
than the negative control) and/or a positive sIgE (>0.35 kU/L) to > 1/14 of the 
allergens tested for. 
Atopic disease in the family was defined as a positive response to the question: Does 




Continuous variables are presented as means with standard deviation (SD) or 95% 
confidence intervals (95% CI) and categorical data as counts and percentages (%). 
To assess possible differences between groups we used Pearson`s chi square-test for 
categorical data and Student’s t-test for continuous data. When comparing the 




variables and paired-sample t-test continuous variables. All tests were two-sided 
using a significance level of 0.05. Odds ratios were estimated by conditional logistic 
regression using Cox proportional hazards model with a constant dependent variable. 
Building the model we first assessed whether an independent variable was a potential 
confounder. Of potential risk factors, the most relevant relationships were assessed in 
unadjusted analysis and factors with an unadjusted p-value < 0.25 were included in 
the model. Variables considered as mediators or colliders were not included. 
Variables in the multivariable model were excluded in a stepwise fashion to increase 
the strength of the model regardless of significance. The final model included 
statistically significant covariates as well as confounders whether or not formally 
statistically significant at the 5% level. All analyses were made using the Statistical 
Package for the Social Sciences (SPSS) software version 22.0 (IBM Corporation, 
Armonk, New York, USA). 
 
Ethical approval 
The Regional Committee for Medical and Health Research Ethics, Northern Norway 




Demographic data from the study populations in 1985 (n = 207) and 2008 (n = 801) 
are displayed together with data from the subgroups of current asthmatic cases and 
non-asthmatic controls in each study (Table 1). In both case-control studies, we 
found a male dominance of 65.7% in 1985 and 61.2% in 2008, and the mean age was 
11.4 years (SD 1.6) and 12.5 years (SD 1.9), respectively. Atopic disease in the 




the subgroups were similar in terms of demographic data and clinical characteristics. 
Comparing demographic and clinical data between genders displayed a significant 
difference in the prevalence of AR in the 2008 study (boys 38.4% and girls 30.5%; p 
= 0.024), while there were no differences in 1985 (data not shown). 
 
The 1985 study 
In 1985, a total of 105 cases and 102 controls participated. Of the 105 cases, 62 
fulfilled the criteria for current asthma (Figure 1). Following the severity definitions  
(9), 39 suffered from mild asthma, 20 suffered from moderate asthma and three 
suffered from severe asthma. Comparing these to their respective controls revealed 
associations between some variables and the outcome current asthma (Table 2). The 
variables not included were either confounding factors or colliders or did not 
strengthen the model. The final model revealed significant differences between cases 
and their matched controls in [aOR (95% CI); repeated LRTIs OR 52.11 (95% CI 
4.62-587.97), urticaria ever in the child OR 11.27 (95% CI 1.01-125.33), atopy in the 
family OR 13.20 (95% CI 1.60-108.63) and duration of breastfeeding OR 1.35 (95% 
CI 1.02-1.80) (Table 2). Analysis of gender specific risk factors for the 1985 survey 
was not performed since the small number of female pairs (12/19 pairs with 
complete data) rendered the results uncertain due to lack of statistical power.  
 
The 2008 study 
Of the 323 cases, 153 fulfilled the criteria for current asthma (Figure 2). According 
to the GINA guidelines  (10) 69 of the cases suffered from intermittent asthma and 
84 suffered from mild persistent asthma. Comparing them to their controls revealed 




3). After establishing the final model, the majority of associations failed to maintain 
their significance. The final model included a total of seven variables: duration of 
breastfeeding, mean number of hours watching television and/or data during 
weekdays, AR, food allergy, LRTI during the first three years of life, hospitalisation 
caused by LRTIs and allergic sensitisation (Table 3). The variables not included 
were either confounding factors or colliders or did not strengthen the model. The 
explained variance for current asthma by all seven variables was 61% with the most 
important risk factors; food allergy OR 7.06 (95% CI 1.61-31.07), LRTI during the 
first 3 years of life OR 5.80 (95% CI 1.96-17.21), and hospitalisation caused by 
LRTIs OR 4.60 (95% CI 1.01-20.96) (Table 3). The only factor associated with a 
reduced risk for current asthma was length of breastfeeding OR 0.93 (95% CI 0.87-
0.99). Restricting the model to include only statistically significant variables did not 
affect the estimated ORs or the explained variance (R2 =61%) to any relevant extent.  
 
Analysing the present data by gender displayed some differences from the data for 
all children. For boys (80/97 matched case-control pairs) food allergy OR 18.32 
(95% CI 1.54-217.74), LRTIs during the first 3 years of life OR 8.87 (95% CI 2.07-
37.96) and AR OR 4.12 (95% CI 1.10-15.4) were significantly different between 
cases and controls, while allergic sensitisation, duration of breastfeeding and time 
spent in front of television or data was not. For girls (44/56 matched case-control 
pairs) LRTI during the first 3 years of life OR 7.70 (95% 1.18-50.36), duration of 
breastfeeding OR 0.89 (95% 0.79-0.99) and time spent in front of television or data 
OR 1.65 (95% CI 1.11-2.45) were significantly different between the cases and 
controls. Analyses of gender specific risk factors did not reveal a gender-dependent 







The main finding in the present study was that one or repeated LRTIs during the first 
three years of life, reported by the parents, was the strongest risk for current asthma 
in both 1985 and 2008, together with severe LRTIs in the 2008 study. These results 
were supported by others studies showing that early severe LRTIs are associated 
with up to a four-fold risk of subsequent wheezing during early school years  (14). In 
addition the number and severity of early life bronchial obstructive episodes has been 
shown to have the greatest impact on risk of pubertal asthma  (15). Recent research 
from Copenhagen Prospective Studies on Asthma in Childhood revealed that 
otherwise healthy children experienced a median of 10 episodes of respiratory tract 
infections (one episode per child for LRTIs) during the first 3 years of life  (16). 
Findings in this Danish study suggest that host factors are the major determinants of 
infection susceptibility in early childhood  (16). Whether the infection susceptibility 
in early childhood has changed during recent decades making an increase in the 
incidence of respiratory tract infections, is unknown. Whether LRTIs has contributed 
to the increased asthma prevalence in our study population needs further 
investigations. 
 
Males (> 60%) dominated both case-control cohorts, in accordance with a 
significantly higher prevalence for asthma ever and current asthma in boys in the 
original study groups  (7). Until teenage years, the prevalence of asthma is higher 




incidence and lower remission prevalence in girls  (17). Since the mean ages were 
12.5 and 11.4 years respectively, male dominance was expected.  
 
Although gender difference in asthma prevalence is well documented, gender-
dependant risk factors for wheeze or asthma have not been fully elucidated  (18). 
Stratification by gender in the 2008 study displayed gender-dependant risk factors: 
comorbidity of AR and food allergies was significantly different between cases and 
controls in boys. Although these associations were strong, this could be the result of 
a higher prevalence of AR in boys in the original study groups  (7) and twice as 
many matched pair of boys than girls in the study.  
 
Despite the known coexistence of asthma and food allergy, the mechanisms are still 
unresolved. Food allergy and atopic dermatitis commonly coexist at the beginning of 
the ‘atopic march’. Questioned has been asked as to whether the observed 
association between asthma and food allergy is related to co-manifestation or if it is a 
consequence of food allergy itself  (19). AR and asthma frequently coexist  (20). Our 
findings are in line with results from the Environment and childhood asthma study 
from Oslo, Norway  (21) and support the hypothesis that asthma and combinations of 
allergic comorbidities may represent a gender-related phenotype.  Increased 
prevalence of AR between 1985-2008  (7) may indicate that it has contributed to the 
increased prevalence of asthma. 
 
The greatest distinctions between the results in 1985 and 2008 were the lack of a 
protective effect of breastfeeding on current asthma and the significance of atopy in 




indicate that breastfeeding for a longer period was protective against the 
development of current asthma. However, the result from the 1985 study showed the 
opposite: longer duration of breastfeeding being a risk factor for current asthma. This 
may be an example of inverse causation where debut of asthma symptoms tends to 
prolong the duration of breast-feeding because of the general belief in its protective 
effect. Such inverse causation could be misinterpreted, drawing the conclusion that 
longer breast-feeding leads to asthma, when in fact it is reverse  (22,23). Breast-
feeding presumably has a protective effect against viral respiratory infections  (24). 
In the present study where LRTI shows a strong association towards current asthma, 
the association to breastfeeding might be brought about by its protective effect 
against LRTIs  (25).  
 
In the 1985 study, current asthma was associated with family atopy, but not parental 
atopy alone. Unlike other studies  (3,4), we were unable to find an association 
between current and parental asthma, AR and/or eczema in the 2008 survey. 
Between the case-control studies, a substantial increase (up to 70%) in the 
prevalence of atopic diseases among family members in Nordland has been 
demonstrated  (7). This high prevalence regardless of asthma status in the child, may 
partly explain the difference. Some researchers have claimed there is a gender-
dependent association of parental atopy with childhood asthma  (26), but we did not 
find such an association. In addition, we were unable to find any association between 
current asthma and allergic sensitisation, second-hand smoke exposure, animal 





In the 2008 case-control study no cases suffered from moderate or severe asthma in 
contrast to the 1985 study where 23 of 62 children did. Even if the severity 
definitions used in the two studies were not identical, we believe this may reflect a 
change in disease severity. Similarly, the ISAAC studies have revealed that the 
overall increase in asthma prevalence reflects milder disease  (27) and a decreasing 
prevalence of severe asthma symptoms  (28). The West Sweden Asthma Study 
(WSAS) using multi-symptom asthma as a marker for severe asthma  (29), found a 
strong association with a familiar history of asthma and allergy, female gender and a 
high body mass index. These factors lacking significance in our study might suggest 
that risk spectrums may be linked to the severity of asthma or even represent a 
phenotype.  
 
Strength and limitations 
The study cohorts in 1985 and 2008 were large and consisted of unselected children 
in Nordland county randomly selected, making the study group a representative 
fraction of the general childhood population. In 1985, both the cross-sectional survey 
and the case-control study had high response rates, making results more reliable. A 
major advantage of the case-control studies was the substantial clinical 
characterisation of the participating children together with detailed questionnaires 
and structured interviews. In addition, we studied children with current asthma to 
ensure more reliable cases regarding recall biases and increased awareness in the 
population.  
 
The study had some limitations. Asthma and allergic diseases have been given 




same period as the ‘asthma epidemic’ has arisen. The increased awareness may have 
contributed to selection bias in the study, since study subjects suffering from a 
disease may be more willing to participate than healthy subjects  (23). The response 
rate of the original cohort in 2008 (63.8%) was lower than desirable  (7). Although a 
high participation rate is preferable to avoid selection biases, most empirical work 
suggests that lower participation rates are not likely to have a substantial influence 
on the measures of interest  (30). As always with retrospective studies, recall bias 
was a risk. Parents with children suffering from asthma, more likely could recount 
their children’s disease history to fit the diagnosis in question. The studies form 1985 
and 2008 were not identical in respect of screening of variables and clinical testing, 
and this was a limitation. Caution was necessary in drawing conclusions, but 
nonetheless we believe that the data and analysis were useful to the overall 
discussion concerning asthma prevalence.  Finally, the reviewers were not blinded to 
the previous parent reported asthma status of the child in the case-control studies. 
Ideally, the reviewers should have been blinded to avoid misclassification based on 
prejudice or beliefs. That this was not possible is one of the unfortunate 
disadvantages of conducting research in environments outside of the university. 
However, the reviewers had no knowledge about the specific answers to individual 
questions in the cross-sectional survey. Thus, we believe that this has only influenced 




Based on similar case-control studies in 1985 and 2008 in a subarctic 




infections during the first three years of life was identified to be the 
most important risk factor for current asthma when adjusting for other 
variables. Whether or not lower respiratory tract infections have 
contributed to the increased asthma prevalence in this population over 
these 23 years is still unresolved. Atopic diseases in the family yielded 
importance in 1985, while food allergy, AR and duration of 
breastfeeding had an impact in the 2008 study. The increased 
prevalence of AR in the period 1985-2008  (7), may indicate that AR 
has contributed to the increased asthma prevalence in the study 
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AR allergic rhinoconjunctivitis 
CI confidence interval 
IgE immunoglobulin E 
LRTIs lower respiratory tract infections 
OR odds ratio 






Table 1. Demographic data given for the study groups in the two case-control studies from 1985 and 2008. Data are displayed for each study in exact numbers 
and percentages (%) or standard deviation (SD) in brackets, for all children and for the subgroups current asthmatic cases and non-asthmatic controls. 
  Case-control studies 
 1985 2008 
  n All children                
Current 
asthmatic 
cases           
Non-
asthmatic  
controls           
p 
value 









Number of study subjects (n)  207 62 62   801 153 153  
Asthma ever as evaluated by a doctor (%) 207 105 (50.7)    801 323 (40.3)    
Gender (male) (%) 207 136 (65.7) 43 (69.4) 43 (69.4) 1.000 801 490 (61.2) 97 (63.4) 97 (63.4) 1.000 
Age (years)  (m ± SD)* 207 11.4 (1.6) 11.2 (1.4) 11.3 (1.5) 0.946 801 12.5 (1.9) 12.6 (1.9) 12.5 (1.9) 0.810 
BMI** (kg/m2) (m ± SD)* 194 17.7 (2.5) 17.9 (2.2) 17.4 (1.8) 0.237 801 19.9 (3.9) 20.6 (4.4) 19.4 (3.6) 0.007 
Birth weight (grams)  (m ± SD)* 202 3464 (568.2) 3390 (569) 3232 (930) 0.263 777 3509 (656.7) 3449 (669) 3538 (631) 0.242 
Number of siblings  (m ± SD)* 204 1.7 (1.2) 1.7 (1.0) 1.6 (1.0) 0.646 790 1,9 (1.0) 2.0 (1.0) 2.1 (1.0) 0.773 
Passive smoke exposition first year of life (%) 204 150 (73.5) 45 (72.6) 44 (72.1) 0.956 791 323 (40.8) 65 (42.8) 62 (40.8) 0.727 
Familiar atopy (%) 205 120 (58.5) 47 (77.0) 30 (49.2) 0.001 794 587 (73.9) 127 (84.7) 104 (68.0) 0.001 
Parental atopy (%) 205 94 (45.4) 38 (62.3) 23 (37.7) 0.007 799 478 (59.8) 93 (60.8) 78 (51.0) 0.084 
Parental asthma (%)  24 (11.6) 11 (18.0) 3 (4.9) 0.023  200 (25.0) 51 (33.3) 29 (19.0) 0.004 
Parental allergic rhinoconjunctivitis (%)  33 (15.9) 17 (27.9) 6 (9.8) 0.011  274 (34.3) 62 (40.5) 47 (30.7) 0.073 
*Mean ± standard deviation                  






Table 2. The potential risk factors (univariable p < 0.25) between the case-control groups in the 1985 study. Adjusted odds ratios (OR)  
are displayed for the variables included in the final multivariable model. 
Risk factor 
Current 
asthmatics      
n = 62 
Non - 
asthmatics     








Adjusted OR    
(95% CI) 
Demographic characteristics        
Duration of breastfeeding (months) (m ± SD)* 5.1 (6.2) 3.5 (2.8) 49 1.10  0.096 43 1.35 (1.02-1.80) 
BMI** (kg/m2) (m ± SD)* 17.8 (2.2) 17.4 (1.8) 51 1.14  0.221   
Passive smoke exposition today (%) 28 (46.7) 34 (57.6) 59 0.61  0.198   
Household animals in the first year of life (%) 30 (49.2) 24 (40.7) 61 0.81  0.159   
Animals in the household today (%) 25 (41.7) 31 (54.4) 57 0.63  0.213   
Furry pets in household today (%) 18 (30.0) 28 (49.1) 58 0.42  0.040   
Comorbidity in the child        
Colic (> 3 weeks) during the first months of life (%) 18 (29.5) 7 (11.7) 61 3.00  0.033   
Allergic rhinoconjunctivitis (%) 50 (80.6) 7 (11.3) 62 65.29  0.001   
Eczema (%) 19 (31.1) 7 (11.3) 62 3.60  0.011   
Food allergy (%) 15 (24.6) 5 (8.2) 62 4.67  0.015   
Urticaria (%) 18 (30.5) 5 (8.8) 56 4.67  0.015 43 11.27 (1.01-125.33) 
Airway infections during the child first 3 years of life        
Repeated RTIs during the first 3 years of life 34 (55.7) 5 (8.5) 59 10.33  0.000 43 52.11 (4.62-587.97) 
Familiar history of atopic diseases        
Family atopy (%) 46 (76.7) 30 (50.0) 61 3.13  0.005 43 13.20 (1.60-108.63) 
Parental atopy (%) 37 (61.7) 23 (38.3) 61 2.67  0.012   
Parental asthma (%) 11 (18.3) 3 (5.0) 61 5.00  0.038     
The difference prevalence (%) between the current asthmatic cases and non-asthmatic controls is quantified by odds ratios (OR).  
P-values or corresponding 95 % confidence intervals (95% CI) are presented.              
*Mean ± standard deviation        




Table 3. The potential risk factors (univariable p < 0.25) between the case-control groups in the 2008 study. Adjusted odds ratios (OR) are  
displayed for the variables included in the final multivariable model.  
Risk factor 
Current 
asthmatics      
n = 153  
Non - 
asthmatics     








Adjusted OR    
(95% CI) 
 
Demographic characteristics         
Mothers smoking in pregnancy or in the first year of life (%) 51 (33.3) 38 (24.8) 153 1.54  0.102    
Birth weight (grams) (m ± SD)* 3449 (669) 3538 (631) 148 1.00  0.193    
Exclusively breastfeeding (%) 115 (75.7) 125 (82.8) 150 0.65  0.112    
Duration of breastfeeding (months)(m ± SD)* 9.4 (6.0) 12.3 (8.6) 145 0.94  0.001 122 0.93 (0.87-0.99)  
BMI** (kg/m2) (m ± SD)* 20.6 (4.4) 19.4 (3.6) 153 1.09  0.007    
Fathers education (years) (m ± SD)* 13.0 (2.9) 13.6 (2.7) 143 0.92  0.059    
Mean number of hours in front of television and/or data during 
weekdays (SD)* 
3.7 (2.4) 3.0 (1.8) 142 1.18  0.007 122 1.34 (1.07-1.68) 
 
Mean number of hours in front of television and/or data during 
weekends (SD)* 
4.7 (2.4) 4.1 (1.8) 135 1.21  0.009   
 
Animals in the household today (%) 67 (43.8) 84 (54.9) 153 0.62  0.049    
Furry pets in household today (%) 56 (36.6) 78 (51.0) 153 0.53  0.011    
Comorbidity in the child         
Colic (> 3 weeks) during the first months of life (%) 36 (23.5) 26 (17.0) 153 1.50  0.160    
Allergic rhinoconjunctivitis (%) 94 (61.4) 35 (22.9) 153 5.21  0.000 122 2.51 (1.03-6.15)  
Food allergy (%) 38 (24.8) 6 (3.9) 153 11.67  0.000 122 7.06 (1.61-31.07)  
Eczema (%) 85 (55.6) 58 (37.9) 153 1.93  0.004    
Urticaria (%) 41 (26.8) 23 (15.0) 153 1.95  0.018    
Allergic sensitization (positive SPT and/or positive sIgE) 117 (78.0) 64 (45.7) 138 3.44  0.000 122 2.16 (0.92-5.06)  
At least one positive specific IgE (%) 94 (74.6) 57 (43.2) 108 3.21  0.000    




Airway infections during the child first 3 years of life         
Hospitalization caused by LRTIs the first 3 years of life (%)**** 41 (27.0) 9 (6.0) 150 7.40  0.000 122 4.60 (1.01-20.96)  
Number of treatments with antibiotics (SD)* 4.0 (6.0) 1.5 (2.4)  136 1.28  0.000    
A common cold during the first 6 months of life (%) 60 (41.7) 29 (19.6) 139 3.29  0.000    
A LRTI during the first year of life (%)**** 45 (29.6) 8 (5.3) 151 8.20  0.00    
A LRTI during the first 3 years of life (%)****  64 (41.8) 14 (9.2) 153 6.56  0.000 122 5.80 (1.96-17.21)  
Tonisilitt during the first year of life (%) 4 (2.7) 13 (8.5) 150 0.18  0.027    
Otitis media during the first year of life (%) 15 (10.0) 24 (15.7) 150 0.61  0.143    
Laryngittis during the first year of life (%) 21 (14.0) 10 (6.5) 150 2.38  0.040    
Laryngittis during the first 3 year of life (%) 28 (18.5) 20 (13.1) 151 1.44  0.230    
Familiar history of atopic diseases         
Familiar atopy (asthma, AR and/or eczema) (%) 127 (83.0) 104 (68.0) 150 2.47  0.002    
Parental atopy (asthma, AR and/or eczema) (%) 93 (60.8) 78 (51.0) 150 2.04  0.005    
Familiar asthma (%) 77 (50.3) 44 (28.8) 150 2.55 0.000    
Parental asthma (%) 51 (33.3) 29 (19.0) 150 2.28  0.004    
Mother asthma (%) 29 (19.3) 17 (11.1) 150 2.00  0.041    
Father asthma (%) 26 (17.3) 13 (8.5) 150 2.18  0.032    
Familiar AR (%) 77 (51.3) 64 (41.8) 150 1.43  0.106    
Parental AR (%) 62 (41.3) 47(30.7) 150 1.55  0.058    
Mother AR (%) 44 (29.3) 32 (20.9) 150 1.54  0.087    
Familiar eczema (%) 71 (47.3) 57 (37.3) 150 1.59  0.058      
The difference prevalence (%) between the current asthmatic cases and non-asthmatic controls is quantified by odds ratios (OR).  
P-values or corresponding 95 % confidence intervals (95% CI) are presented. 
*Mean ± standard deviation         
**BMI (body mass index) = weight/height2         
***skin prick test (SPT)         






Figure 1. Subject flow chart in the study of asthma and allergic diseases among 







Figure 2. Subject flow chart in Asthma and allergy among schoolchildren in 
Nordland county 2008.  
aSubjects misclassified as non-asthmatics (n=14).  
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